Cellectis (CLLS) Invested Capital (2015 - 2026)

Cellectis' Invested Capital history runs 12 years deep, the most recent figure standing at $8.9 million for Q1 2026.

• On a quarterly basis, Invested Capital fell 46.96% year-over-year to $8.9 million in Q1 2026; TTM through Mar 2026 was $159.5 million, a 3.74% decrease from a year earlier, with the FY2025 full-year figure at $114.1 million, down 17.57% from the prior year.
• Invested Capital declined to $8.9 million in Q1 2026 per CLLS's latest filing, from $114.1 million in the prior quarter.
• Across five years, Invested Capital topped out at $138.4 million in Q4 2024 and bottomed at $5.1 million in Q3 2023.
• The 5-year median for Invested Capital is $11.3 million (2022), against an average of $30.1 million.
• Across the five-year window, Invested Capital plunged 88.26% in 2023 and jumped 903.68% in 2024, its largest moves.
• Year by year, Invested Capital stood at $117.5 million in 2022, then plunged by 88.26% to $13.8 million in 2023, then soared by 903.68% to $138.4 million in 2024, then decreased by 17.57% to $114.1 million in 2025, then tumbled by 92.2% to $8.9 million in 2026.
• Per Business Quant, the three latest CLLS Invested Capital figures stand at $8.9 million (Q1 2026), $114.1 million (Q4 2025), and $18.2 million (Q3 2025).